DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fispemifene
Fispemifene
Forendo Pharma Announces the US Licensing of Fispemifene to Apricus Biosciences Targeting Urological Conditions in Men
TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub
Treating Endometriosis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis
Studies of Protein S-Nitrosylation in Prostate Cancer Focused on Integrin Alpha 6, Proliferating Cell Nuclear Antigen and Estrogen Receptor Beta
Serms Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
( 12 ) United States Patent
HUMUUUUUUUUUUUS009744149B2 (12 ) United States Patent (10 ) Patent No
Customs Tariff - Schedule
Quatrx Pharmaceuticals Company 777 East Eisenhower Parkway, Suite 100 Ann Arbor, MI 48108 (734) 913-9900 • Fax (734) 913-0743
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Small-Cap Research Brian Marckx, CFA 312-265-9474 /
[email protected]
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Method for the Treatment Or Prevention of Lower Urinary Tract Symptoms
Top View
Tackling the Endometriosis Challenge Scrip Pharma Intelligence
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Treatment of Hot Flushes, Vasomotor Symptoms, and Night Sweats with Sex Steroid Precursors in Combination with Selective Estrogen Receptor Modulators
FIG. 1 an Antiestrogen, Preferably a Selective Estrogen Receptor Modulator (SERM) Such As Trans-Clomi- Phene, for Treating Cancer and Associated Dis Eases
WO 2009/039344 Al
Quatrx Closes $44 Million Series E Private Equity Financing Funding To
WO 2015/092614 Al ©
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
An Experimental Model of Prostatic Inflammation for Drug Discovery